Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2316683
Max Phase: Preclinical
Molecular Formula: C43H61N3O11
Molecular Weight: 795.97
Molecule Type: Small molecule
Associated Items:
ID: ALA2316683
Max Phase: Preclinical
Molecular Formula: C43H61N3O11
Molecular Weight: 795.97
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)/C(=N\OC/C=C/c2cnc3ccccc3c2)[C@H](C)[C@H]2OC(=O)O[C@@]21C
Standard InChI: InChI=1S/C43H61N3O11/c1-12-33-43(8)38(56-41(50)57-43)26(4)34(45-52-19-15-16-29-21-30-17-13-14-18-31(30)44-23-29)24(2)22-42(7,51-11)37(27(5)35(47)28(6)39(49)54-33)55-40-36(48)32(46(9)10)20-25(3)53-40/h13-18,21,23-28,32-33,36-38,40,48H,12,19-20,22H2,1-11H3/b16-15+,45-34+/t24-,25-,26+,27+,28-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1
Standard InChI Key: GPMSCAIHDUSNFA-JFJRPKKDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 795.97 | Molecular Weight (Monoisotopic): 795.4306 | AlogP: 5.97 | #Rotatable Bonds: 9 |
Polar Surface Area: 164.54 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 1 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.93 | CX Basic pKa: 8.27 | CX LogP: 7.03 | CX LogD: 6.42 |
Aromatic Rings: 2 | Heavy Atoms: 57 | QED Weighted: 0.14 | Np Likeness Score: 1.02 |
1. Liang JH, An K, Lv W, Cushman M, Wang H, Xu YC.. (2013) Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides., 59 [PMID:23202851] [10.1016/j.ejmech.2012.10.054] |
2. Liang JH, Lv W, Li XL, An K, Cushman M, Wang H, Xu YC.. (2013) Synthesis and antibacterial activity of 9-oxime ether non-ketolides, and novel binding mode of alkylides with bacterial rRNA., 23 (5): [PMID:23375796] [10.1016/j.bmcl.2012.12.070] |
3. Han X, Lv W, Guo SY, Cushman M, Liang JH.. (2015) Synthesis and structure-activity relationships of novel 9-oxime acylides with improved bactericidal activity., 23 (19): [PMID:26349628] [10.1016/j.bmc.2015.08.020] |
4. Tian JC, Han X, Lv W, Li YX, Wang H, Fan BZ, Cushman M, Liang JH.. (2017) Design, synthesis and structure-bactericidal activity relationships of novel 9-oxime ketolides and reductive epimers of acylides., 27 (7): [PMID:28256375] [10.1016/j.bmcl.2017.02.041] |
Source(1):